USPTO serial 79198945
PHARMALP
Reviewed by CopyMark Law Group
Reg. 5352587Status 404
- Filing date
- Status date
- Registration date
- Dec 12, 2017
- Examiner
- LAM, HAI-LY HUYNH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PHARMALP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew M. Smith
Andrew M. Smith Resonate IP, LLCP.O. Box 1650Bend, OR 97709UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Soaps, in particular anti-bacterial soap, body soaps, cosmetic soaps, disinfectant soaps, deodorant soaps, soaps for personal use, soaps for body care and bath soaps in liquid, solid or gel form; washing preparations for personal hygiene; perfumery; extracts of flowers for use as perfumes; essential oils; cosmetics and cosmetic preparations; cosmetics and cosmetic preparations for beauty care and for care of the skin, face, eyes, lips, hands, scalp, hair, nails, feet or body; cosmetics and cosmetic preparations in the form of powders, gels, emulsions, creams, milks, lotions, oils, balms or sprays; skin moisturizing creams, lotions and gels; anti-aging gels; anti-aging creams; cosmetics, namely, after-sun creams and gels; massage gels other than for medical use; bath and shower gels other than for medical use; bath creams; non-medicated topical herbal skin creams; cleansing creams; perfumed creams; hair lotions; dentifrices; tooth gels; dental bleaching gels; non-medicated mouthwashes and gargles; gargles not for medical use | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical products, namely, pharmaceutical products for the regulation of the nervous system, pharmaceutical products for the regulation of psychological functions, pharmaceutical products for maintaining energy metabolism, pharmaceutical products for maintaining body metabolism, pharmaceutical products for maintaining sleep quality, pharmaceutical products for strengthening the immune system of the body, pharmaceutical products for reducing the duration and intensity of winter infections, pharmaceutical products for soothing sore throats, pharmaceutical products for preventing and reducing the symptoms associated with atopic dermatitis, pharmaceutical products for preventing and reducing the symptoms associated with food intolerances, pharmaceutical products for maintaining microflora balance, pharmaceutical products for maintaining digestive functions, pharmaceutical products for improving the microflora, pharmaceutical products for maintaining the immune system, pharmaceutical products for maintaining a healthy balance of intestinal flora, pharmaceutical products for maintaining a healthy balance of vaginal flora, pharmaceutical products for preventing vaginal mycosis in the nature of vaginal thrush, pharmaceutical products for preventing bacterial vaginosis, pharmaceutical products for hydrating the mucous membranes to prevent vaginal dryness, pharmaceutical products for reducing inflammation, pharmaceutical products for hydrating and soothing weakened skin, pharmaceutical products for cooling and soothing sensitive or reactive skin, namely, redness caused by exposure to the sun, insect bites, nettle stings and itching, pharmaceutical products for restoring hydrolipid film in the skin, pharmaceutical products for ensuring normal cognitive function, pharmaceutical products for the promotion of normal energy metabolism, pharmaceutical products for the promotion of normal formation of red blood cells and hemoglobin, pharmaceutical products for the promotion of normal transportation of oxygen around the body, and pharmaceutical products for helping the immune system to operate normally; pharmaceutical preparations to prevent fatigue, migraines and headaches, prevent brittle nails and hair, strengthen nails, improve pallor, decrease hypersensitivity to the cold, prevent weakening of the immune system and to decrease concentration difficulties; pharmaceutical preparations based on minerals, iron, trace elements, vitamins, essential fatty acids, antioxidants, proteins or vegetable or mineral fibers, namely, pharmaceutical preparations for the regulation of the nervous system, pharmaceutical preparations for the regulation of psychological functions, pharmaceutical preparations for maintaining energy metabolism, pharmaceutical preparations for maintaining body metabolism, pharmaceutical preparations for maintaining sleep quality, pharmaceutical preparations for strengthening the immune system of the body, pharmaceutical preparations for reducing the duration and intensity of winter infections, pharmaceutical preparations for soothing sore throats, pharmaceutical preparations for preventing and reducing the symptoms associated with atopic dermatitis, pharmaceutical preparations for preventing and reducing the symptoms associated with food intolerances, pharmaceutical preparations for maintaining microflora balance, pharmaceutical preparations for maintaining digestive functions, pharmaceutical preparations for improving the microflora, pharmaceutical preparations for maintaining the immune system, pharmaceutical preparations for maintaining a healthy balance of intestinal flora, pharmaceutical preparations for maintaining a healthy balance of vaginal flora, pharmaceutical preparations for preventing vaginal mycosis in the nature of vaginal thrush, pharmaceutical preparations for preventing bacterial vaginosis, pharmaceutical preparations for hydrating the mucous membranes to prevent vaginal dryness, pharmaceutical preparations for reducing inflammation, pharmaceutical preparations for hydrating and soothing weakened skin, pharmaceutical preparations for cooling and soothing sensitive or reactive skin, namely, redness caused by exposure to the sun, insect bites, nettle stings and itching, pharmaceutical preparations for restoring hydrolipid film in the skin, pharmaceutical preparations for ensuring normal cognitive function, pharmaceutical preparations for the promotion of normal energy metabolism, pharmaceutical preparations for the promotion of normal formation of red blood cells and hemoglobin, pharmaceutical preparations for the promotion of normal transportation of oxygen around the body, and pharmaceutical preparations for helping the immune system to operate normally; pharmaceutical products in the form of gels, granules, tablets, capsules, powder or liquid, namely, pharmaceutical products for the regulation of the nervous system, pharmaceutical products for the regulation of psychological functions, pharmaceutical products for maintaining energy metabolism, pharmaceutical products for maintaining body metabolism, pharmaceutical products for maintaining sleep quality, pharmaceutical products for strengthening the immune system of the body, pharmaceutical products for reducing the duration and intensity of winter infections, pharmaceutical products for soothing sore throats, pharmaceutical products for preventing and reducing the symptoms associated with atopic dermatitis, pharmaceutical products for preventing and reducing the symptoms associated with food intolerances, pharmaceutical products for maintaining microflora balance, pharmaceutical products for maintaining digestive functions, pharmaceutical products for improving the microflora, pharmaceutical products for maintaining the immune system, pharmaceutical products for maintaining a healthy balance of intestinal flora, pharmaceutical products for maintaining a healthy balance of vaginal flora, pharmaceutical products for preventing vaginal mycosis in the nature of vaginal thrush, pharmaceutical products for preventing bacterial vaginosis, pharmaceutical products for hydrating the mucous membranes to prevent vaginal dryness, pharmaceutical products for reducing inflammation, pharmaceutical products for hydrating and soothing weakened skin, pharmaceutical products for cooling and soothing sensitive or reactive skin, namely, redness caused by exposure to the sun, insect bites, nettle stings and itching, pharmaceutical products for restoring hydrolipid film in the skin, pharmaceutical products for ensuring normal cognitive function, pharmaceutical products for the promotion of normal energy metabolism, pharmaceutical products for the promotion of normal formation of red blood cells and hemoglobin, pharmaceutical products for the promotion of normal transportation of oxygen around the body, and pharmaceutical products for helping the immune system to operate normally; veterinary products, namely, veterinary pharmaceutical preparations for the regulation of the nervous system, veterinary pharmaceutical preparations for the regulation of psychological functions, veterinary pharmaceutical preparations for maintaining energy metabolism, veterinary pharmaceutical preparations for maintaining body metabolism, veterinary pharmaceutical preparations for maintaining sleep quality, veterinary pharmaceutical preparations for strengthening the immune system of the animal body, veterinary pharmaceutical preparations for reducing the duration and intensity of winter infections, veterinary pharmaceutical preparations for preventing and reducing the symptoms associated with atopic dermatitis, veterinary pharmaceutical preparations for preventing and reducing the symptoms associated with food intolerances, veterinary pharmaceutical preparations for maintaining microflora balance, veterinary pharmaceutical preparations for maintaining digestive functions, veterinary pharmaceutical preparations for improving the microflora, veterinary pharmaceutical preparations for maintaining the immune system, veterinary pharmaceutical preparations for maintaining a healthy balance of intestinal flora, veterinary pharmaceutical preparations for reducing inflammation, veterinary pharmaceutical preparations for hydrating and soothing weakened skin, veterinary pharmaceutical preparations for cooling and soothing sensitive or reactive skin, namely, redness caused by insect bites, nettle stings and itching, veterinary pharmaceutical preparations for restoring hydrolipid film in the skin, veterinary pharmaceutical preparations for ensuring normal cognitive function, veterinary pharmaceutical preparations for the promotion of normal energy metabolism, veterinary pharmaceutical preparations for the promotion of normal formation of red blood cells and hemoglobin, veterinary pharmaceutical preparations for the promotion of normal transportation of oxygen around the animal body, and veterinary pharmaceutical preparations for helping the immune system to operate normally; sanitary preparations for medical purposes; sanitary preparations for personal hygiene other than toiletries, namely, hand-sanitizing preparations and disinfectants for hygienic purposes; antibacterial gels in the nature of antibacterial alcohol skin sanitizer gel; gels for use as personal lubricants; gels, creams and solutions for dermatological use; topical first aid gels; topical gels for medical or therapeutic treatment of allergies, vaginal mycosis in the nature of vaginal thrush and bacterial vaginosis, vaginal dryness, inflammation, and weakened skin; medicated gels for skin irritations; pharmaceutical preparations and substances with anti-inflammatory properties, in particular anti-inflammatory sprays, ointments, balms and gels; medicinal creams for skin care; antifungal creams for medical use; herbal skin creams for medical use; medicated skin creams; herbal remedies, namely, medicinal herbal preparations; plant and herb extracts for medicinal use; medicinal plant extracts for medical use; plant preparations for medical use, namely, plant preparations for the regulation of the nervous system, plant preparations for the regulation of psychological functions, plant preparations for maintaining energy metabolism, plant preparations for maintaining body metabolism, plant preparations for maintaining sleep quality, plant preparations for strengthening the immune system of the body, plant preparations for reducing the duration and intensity of winter infections, plant preparations for soothing sore throats, plant preparations for preventing and reducing the symptoms associated with atopic dermatitis, plant preparations for preventing and reducing the symptoms associated with food intolerances, plant preparations for maintaining microflora balance, plant preparations for maintaining digestive functions, plant preparations for improving the microflora, plant preparations for maintaining the immune system, plant preparations for maintaining a healthy balance of intestinal flora, plant preparations for maintaining a healthy balance of vaginal flora, plant preparations for preventing vaginal mycosis in the nature of vaginal thrush, plant preparations for preventing bacterial vaginosis, plant preparations for hydrating the mucous membranes to prevent vaginal dryness, plant preparations for reducing inflammation, plant preparations for hydrating and soothing weakened skin, plant preparations for cooling and soothing sensitive or reactive skin, namely, redness caused by exposure to the sun, insect bites, nettle stings and itching, plant preparations for restoring hydrolipid film in the skin, plant preparations for ensuring normal cognitive function, plant preparations for the promotion of normal energy metabolism, plant preparations for the promotion of normal formation of red blood cells and hemoglobin, plant preparations for the promotion of normal transportation of oxygen around the body, and plant preparations for helping the immune system to operate normally; herbal sprays for medical use; dietetic food and substances in the nature of amino acids, peptides, vitamins and minerals, all adapted for medical or veterinary use; food for babies; dietary food supplements for humans and animals; probiotic dietary food supplements; dietary food supplements for enhancing the balance of intestinal flora, promote digestion or to combat diarrhea; dietary food supplements based on minerals, iron, trace elements, vitamins, essential fatty acids, antioxidants, proteins or vegetable or mineral fibers; antioxidants used as dietary food supplements; disinfectants; medicated oral care gels; gargles for medical use; medicated mouth washes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 18, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Oct 18, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jun 28, 2024 | C71T | CANCELLED SECTION 71 | — |
| Feb 26, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 26, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 12, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 18, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 18, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 18, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 11, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 26, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 26, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 12, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 12, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 26, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 26, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 6, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 15, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 15, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 14, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 14, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 18, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 18, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 18, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 30, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 29, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 29, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 10, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 23, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 23, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 18, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 17, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 11, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 7, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 5, 2017 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 22, 2016 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |